Winsome Chung
VP of Finance
San Francisco, California, United States
Professional Overview
Winsome Chung is a seasoned finance executive with over 20 years of experience in the biopharmaceutical industry. As the VP of Finance at Lycia Therapeutics, she oversees all financial planning, analysis, and reporting for the fast-growing biotechnology company. Chung is known for her strategic financial leadership, operational expertise, and ability to drive business growth through data-driven decision-making.
Experience Summary
Current Role
As the VP of Finance at Lycia Therapeutics, Chung is responsible for leading the company's financial strategy, budgeting, forecasting, and reporting. She works closely with the executive team to provide critical financial insights that support key business initiatives and drive value creation. Under her leadership, Lycia has successfully navigated several funding rounds and positioned itself for long-term sustainability.
Career Progression
Prior to joining Lycia, Chung served as the Head of Financial Planning & Analysis at Arsenal Biosciences, where she played a pivotal role in the company's financial planning and analysis during a period of rapid growth. Before that, she held senior finance roles at NGM Biopharmaceuticals, including Executive Director of Financial Planning & Analysis and Controller. In these positions, she was instrumental in implementing robust financial systems, streamlining processes, and contributing to the company's overall strategic direction.
Chung's earlier career experience includes roles as a Finance Manager at Macromedia/Adobe and Associate Director of Finance Planning & Analysis at Anesiva, where she honed her expertise in financial planning, analysis, and reporting.
Academic Background
Winsome Chung holds a Bachelor of Science in Business Administration from the University of California, Berkeley, with a concentration in Accounting and Finance.
Areas of Expertise
- Financial planning, analysis, and reporting
- Budgeting and forecasting
- Cash flow management and treasury operations
- Financial systems and process optimization
- Cross-functional collaboration and communication
- Strategic decision-making and business partnering
Professional Impact
Throughout her career, Chung has consistently demonstrated her ability to drive financial excellence and support the growth of biopharmaceutical companies. At NGM Biopharmaceuticals, she played a pivotal role in the company's successful IPO and subsequent financing activities, securing over $500 million in capital. At Arsenal Biosciences, she developed and implemented a comprehensive FP&A framework that enabled the company to make informed business decisions and achieve its strategic objectives.
Conclusion
With her deep understanding of the biopharmaceutical industry, strong financial expertise, and proven track record of success, Winsome Chung is poised to continue making a significant impact as the VP of Finance at Lycia Therapeutics. Her strategic leadership and collaborative approach position her as a valuable asset in supporting the company's long-term growth and innovation.
